Can Targeting Cell Migration Serve as a Therapeutic Strategy?
Given the crucial role of cell migration in cancer metastasis, targeting the molecular pathways involved in this process offers potential therapeutic strategies. Inhibitors of signaling pathways such as the PI3K/AKT and MAPK pathways, which are often upregulated in cancer, have shown promise in preclinical studies. Additionally, targeting the components of the cytoskeleton or adhesion molecules may help to prevent the spread of cancer cells.
